194 related articles for article (PubMed ID: 15592687)
1. Confirmation of the HPCX prostate cancer predisposition locus in large Utah prostate cancer pedigrees.
Farnham JM; Camp NJ; Swensen J; Tavtigian SV; Albright LA
Hum Genet; 2005 Feb; 116(3):179-85. PubMed ID: 15592687
[TBL] [Abstract][Full Text] [Related]
2. Genomic search for prostate cancer predisposition loci in Utah pedigrees.
Camp NJ; Farnham JM; Cannon Albright LA
Prostate; 2005 Dec; 65(4):365-74. PubMed ID: 16037989
[TBL] [Abstract][Full Text] [Related]
3. Localization of a prostate cancer predisposition gene to an 880-kb region on chromosome 22q12.3 in Utah high-risk pedigrees.
Camp NJ; Farnham JM; Cannon-Albright LA
Cancer Res; 2006 Oct; 66(20):10205-12. PubMed ID: 17047086
[TBL] [Abstract][Full Text] [Related]
4. PCAP is the major known prostate cancer predisposing locus in families from south and west Europe.
Cancel-Tassin G; Latil A; Valéri A; Mangin P; Fournier G; Berthon P; Cussenot O
Eur J Hum Genet; 2001 Feb; 9(2):135-42. PubMed ID: 11313747
[TBL] [Abstract][Full Text] [Related]
5. Linkage analysis of 153 prostate cancer families over a 30-cM region containing the putative susceptibility locus HPCX.
Lange EM; Chen H; Brierley K; Perrone EE; Bock CH; Gillanders E; Ray ME; Cooney KA
Clin Cancer Res; 1999 Dec; 5(12):4013-20. PubMed ID: 10632333
[TBL] [Abstract][Full Text] [Related]
6. Genome-wide linkage analysis for aggressive prostate cancer in Utah high-risk pedigrees.
Christensen GB; Camp NJ; Farnham JM; Cannon-Albright LA
Prostate; 2007 May; 67(6):605-13. PubMed ID: 17299800
[TBL] [Abstract][Full Text] [Related]
7. Genome-wide linkage analysis of 1,233 prostate cancer pedigrees from the International Consortium for Prostate Cancer Genetics using novel sumLINK and sumLOD analyses.
Christensen GB; Baffoe-Bonnie AB; George A; Powell I; Bailey-Wilson JE; Carpten JD; Giles GG; Hopper JL; Severi G; English DR; Foulkes WD; Maehle L; Moller P; Eeles R; Easton D; Badzioch MD; Whittemore AS; Oakley-Girvan I; Hsieh CL; Dimitrov L; Xu J; Stanford JL; Johanneson B; Deutsch K; McIntosh L; Ostrander EA; Wiley KE; Isaacs SD; Walsh PC; Isaacs WB; Thibodeau SN; McDonnell SK; Hebbring S; Schaid DJ; Lange EM; Cooney KA; Tammela TL; Schleutker J; Paiss T; Maier C; Grönberg H; Wiklund F; Emanuelsson M; Farnham JM; Cannon-Albright LA; Camp NJ;
Prostate; 2010 May; 70(7):735-44. PubMed ID: 20333727
[TBL] [Abstract][Full Text] [Related]
8. Dynamic structure of the SPANX gene cluster mapped to the prostate cancer susceptibility locus HPCX at Xq27.
Kouprina N; Pavlicek A; Noskov VN; Solomon G; Otstot J; Isaacs W; Carpten JD; Trent JM; Schleutker J; Barrett JC; Jurka J; Larionov V
Genome Res; 2005 Nov; 15(11):1477-86. PubMed ID: 16251457
[TBL] [Abstract][Full Text] [Related]
9. Hereditary prostate cancer in African American families: linkage analysis using markers that map to five candidate susceptibility loci.
Brown WM; Lange EM; Chen H; Zheng SL; Chang B; Wiley KE; Isaacs SD; Walsh PC; Isaacs WB; Xu J; Cooney KA
Br J Cancer; 2004 Jan; 90(2):510-4. PubMed ID: 14735201
[TBL] [Abstract][Full Text] [Related]
10. A major locus for hereditary prostate cancer in Finland: localization by linkage disequilibrium of a haplotype in the HPCX region.
Baffoe-Bonnie AB; Smith JR; Stephan DA; Schleutker J; Carpten JD; Kainu T; Gillanders EM; Matikainen M; Teslovich TM; Tammela T; Sood R; Balshem AM; Scarborough SD; Xu J; Isaacs WB; Trent JM; Kallioniemi OP; Bailey-Wilson JE
Hum Genet; 2005 Aug; 117(4):307-16. PubMed ID: 15906096
[TBL] [Abstract][Full Text] [Related]
11. Genetic linkage analysis of prostate cancer families to Xq27-28.
Peters MA; Jarvik GP; Janer M; Chakrabarti L; Kolb S; Goode EL; Gibbs M; DuBois CC; Schuster EF; Hood L; Ostrander EA; Stanford JL
Hum Hered; 2001; 51(1-2):107-13. PubMed ID: 11096277
[TBL] [Abstract][Full Text] [Related]
12. Statistical recombinant mapping in extended high-risk Utah pedigrees narrows the 8q24 prostate cancer locus to 2.0 Mb.
Camp NJ; Farnham JM; Allen-Brady K; Cannon-Albright LA
Prostate; 2007 Sep; 67(13):1456-64. PubMed ID: 17654497
[TBL] [Abstract][Full Text] [Related]
13. A genetic epidemiological study of hereditary prostate cancer (HPC) in Finland: frequent HPCX linkage in families with late-onset disease.
Schleutker J; Matikainen M; Smith J; Koivisto P; Baffoe-Bonnie A; Kainu T; Gillanders E; Sankila R; Pukkala E; Carpten J; Stephan D; Tammela T; Brownstein M; Bailey-Wilson J; Trent J; Kallioniemi OP
Clin Cancer Res; 2000 Dec; 6(12):4810-5. PubMed ID: 11156239
[TBL] [Abstract][Full Text] [Related]
14. Confirmation of the prostate cancer susceptibility locus HPCX in a set of 104 German prostate cancer families.
Bochum S; Paiss T; Vogel W; Herkommer K; Hautmann R; Haeussler J
Prostate; 2002 Jun; 52(1):12-9. PubMed ID: 11992616
[TBL] [Abstract][Full Text] [Related]
15. Prostate cancer susceptibility locus HPC1 in Utah high-risk pedigrees.
Neuhausen SL; Farnham JM; Kort E; Tavtigian SV; Skolnick MH; Cannon-Albright LA
Hum Mol Genet; 1999 Dec; 8(13):2437-42. PubMed ID: 10556291
[TBL] [Abstract][Full Text] [Related]
16. Replication of the 10q11 and Xp11 prostate cancer risk variants: results from a Utah pedigree-based study.
Camp NJ; Farnham JM; Wong J; Christensen GB; Thomas A; Cannon-Albright LA
Cancer Epidemiol Biomarkers Prev; 2009 Apr; 18(4):1290-4. PubMed ID: 19336566
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of linkage and association of HPC2/ELAC2 in patients with familial or sporadic prostate cancer.
Xu J; Zheng SL; Carpten JD; Nupponen NN; Robbins CM; Mestre J; Moses TY; Faith DA; Kelly BD; Isaacs SD; Wiley KE; Ewing CM; Bujnovszky P; Chang B; Bailey-Wilson J; Bleecker ER; Walsh PC; Trent JM; Meyers DA; Isaacs WB
Am J Hum Genet; 2001 Apr; 68(4):901-11. PubMed ID: 11254448
[TBL] [Abstract][Full Text] [Related]
18. Genome linkage screen for prostate cancer susceptibility loci: results from the Mayo Clinic Familial Prostate Cancer Study.
Cunningham JM; McDonnell SK; Marks A; Hebbring S; Anderson SA; Peterson BJ; Slager S; French A; Blute ML; Schaid DJ; Thibodeau SN;
Prostate; 2003 Dec; 57(4):335-46. PubMed ID: 14601030
[TBL] [Abstract][Full Text] [Related]
19. Genome-wide linkage screen for testicular germ cell tumour susceptibility loci.
Crockford GP; Linger R; Hockley S; Dudakia D; Johnson L; Huddart R; Tucker K; Friedlander M; Phillips KA; Hogg D; Jewett MA; Lohynska R; Daugaard G; Richard S; Chompret A; Bonaïti-Pellié C; Heidenreich A; Albers P; Olah E; Geczi L; Bodrogi I; Ormiston WJ; Daly PA; Guilford P; Fosså SD; Heimdal K; Tjulandin SA; Liubchenko L; Stoll H; Weber W; Forman D; Oliver T; Einhorn L; McMaster M; Kramer J; Greene MH; Weber BL; Nathanson KL; Cortessis V; Easton DF; Bishop DT; Stratton MR; Rapley EA
Hum Mol Genet; 2006 Feb; 15(3):443-51. PubMed ID: 16407372
[TBL] [Abstract][Full Text] [Related]
20. Perspective: prostate cancer susceptibility genes.
Simard J; Dumont M; Soucy P; Labrie F
Endocrinology; 2002 Jun; 143(6):2029-40. PubMed ID: 12021166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
